Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Similar documents
Compliance of manufacturers of AST materials and devices with EUCAST guidelines

What s new in EUCAST methods?

European Committee on Antimicrobial Susceptibility Testing

EUCAST recommended strains for internal quality control

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

European Committee on Antimicrobial Susceptibility Testing

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

AMR Industry Alliance Antibiotic Discharge Targets

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Antimicrobial Susceptibility Testing: Advanced Course

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

2015 Antibiotic Susceptibility Report

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

2016 Antibiotic Susceptibility Report

British Society for Antimicrobial Chemotherapy

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

British Society for Antimicrobial Chemotherapy

56 Clinical and Laboratory Standards Institute. All rights reserved.

EUCAST-and CLSI potency NEO-SENSITABS

Background and Plan of Analysis

Performance Information. Vet use only

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

BSAC standardized disc susceptibility testing method (version 8)

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1

Antimicrobial Susceptibility Testing: The Basics

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Penicillins - EUCAST clinical MIC breakpoints (version 1.3)

Intrinsic, implied and default resistance

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia

Concise Antibiogram Toolkit Background

CONTAGIOUS COMMENTS Department of Epidemiology

Antimicrobial susceptibility

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

- the details, where possible, of the antibiotic products these companies supply or have supplied.

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Understanding the Hospital Antibiogram

Antimicrobial susceptibility testing challenges. Linda Joyce St Vincent s Hospital Melbourne

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Introduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.

BactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

EUCAST 2016/17 and what to do when there are no breakpoints and if the UK should exit EU

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Available online at ISSN No:

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Advanced Practice Education Associates. Antibiotics

Antibiotic Updates: Part II

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Antimicrobial Susceptibility Patterns

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Discussion Points. Decisions in Selecting Antibiotics

CONTAGIOUS COMMENTS Department of Epidemiology

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

EUCAST Expert Rules for Staphylococcus spp IF resistant to isoxazolylpenicillins

Measuring Antibiotic Use in NHSN

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

EUCAST expert rules in antimicrobial susceptibility testing

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

A Multi-Laboratory Study of the BIOMIC Automated Well Reading Instrument versus

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,

EUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods

Version 7, January 2008

Product Catalogue 2017 Clinical and Industrial Microbiology

This document is protected by international copyright laws.

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

CAP Laboratory Improvement Programs. Performance Accuracy of Antibacterial and Antifungal Susceptibility Test Methods

REVOLUTIONARY. MMinimum. BBiofilm EEradication Concentration. inimizing WE HAVE FOUND THE ANSWER.

TABLE OF CONTENTS. Urine - Gram Positive Susceptibility Reporting 1 Staphylococcus species, MRSA...11

Liofilchem. ID-AST systems

Version 10.1 April 2011

Version 13 January 2014

Should we test Clostridium difficile for antimicrobial resistance? by author

Version 9.1 March 2010

ICAAC. Key words: antibacterial agent development approval. linezolid β. chloramphenicol tetracycline colistin mupirocin teicoplanin

Recommendations to take it forward!

Version 6, January 2007

2 New products for 2014

Version 8 January 2009

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

HUSRES Annual Report 2007 Martti Vaara.

MASTDISCS AST. Leading the field with a complete solution for AST and Identification disc testing. Comprehensive range. Premium quality products

CONTAGIOUS COMMENTS Department of Epidemiology

دکتر فرينبز راشذ مرنذی متخصص آسيب شنبسی تشريحی و ببلينی عضو هيئت علمی آزمبيشگبه مرجع سالمت

Measurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Transcription:

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The tables will be updated when manufacturers report changes (contact erika.matuschek@escmid.org). The accuracy of data in these tables is not verified by EUCAST and the inclusion of any materials or devices does not indicate endorsement by EUCAST. Last updated 10 March 2016

EUCAST disk diffusion method Manufacturer Disks available MH-F plates available Abtek BD Bioanalyse All except ceftobiprole 5 µg and ceftolozane-tazobactam 30-10 µg All except ceftobiprole 5 µg and ceftolozane-tazobactam 30-10 µg All except ceftaroline 5 µg, ceftobiprole 5 µg and ceftolozane-tazobactam 30-10 µg No Expected 2016 No Bio-Rad All except ceftobiprole 5 µg biomérieux No disks marketed I2a Liofilchem All except ceftaroline 5 µg and ceftobiprole 5 µg All except ceftolozane-tazobactam 30-10 µg (expected April 2016) No MAST Group All except ceftobiprole 5 µg No but supply β-nad supplement Thermo Fisher Scientific (Oxoid) All except ceftobiprole 5 µg, ceftolozane-tazobactam 30-10 µg and ticarcillin-clavulanic acid 75-10 µg Rosco All (Neo-Sensitabs) No

Automated systems for reading antimicrobial susceptibility testing plates Manufacturer System EUCAST breakpoints EUCAST Expert Rules EUCAST terminology S R> - Bio-Rad OSIRIS/ADAGIO Giles Scientific BIOMIC V3. There are additional rules but EUCAST rules have priority.. No exceptions I2a SIRSCAN: 2000 2000 automatic Micro. There are additional rules but none should be contrary to EUCAST rules. Synbiosis - Division of Synoptics ChromaZona. EUCAST rule number displayed. No No

Gradient tests: Etest (biomérieux) Manufacturer Agents in EUCAST tables but not available Agents validated for MH-F biomérieux Amoxicillin-clavulanic acid (fixed 2 mg/l clavulanic acid)*, ** Ampicillin-sulbactam (fixed 4 mg/l sulbactam)*, ** Cefadroxil Cefalexin Cefazolin Ceftibuten Ceftobiprole (available for resaerch use only) Ceftolozane-tazobactam (expected 2016) Oritavancin Roxithromycin Tedizolid Ticarcillin Ampicillin Amoxicillin Benzylpenicillin Cefaclor Cefepime Cefixime Cefotaxime Cefpodoxime Ceftriaxone Cefuroxime Doripenem Ertapenem Imipenem Meropenem Chloramphenicol Ciprofloxacin Levofloxacin Moxifloxacin Ofloxacin Azithromycin Clarithromycin Erythromycin Clindamycin Doxycycline Minocycline Tetracycline Tigecycline Teicoplanin Vancomycin Daptomycin Linezolid Nitofurantoin Rifampicin Trimethoprim Trimethoprim-sulfamethoxazole (not for H. influenzae and M. catarrhalis) *Gradient tests with the agent:inhibitor in a 2:1 ratio are not acceptable using EUCAST methods and breakpoints ** Expected during 2014

Gradient tests: MIC Test Strip (Liofilchem) Manufacturer Agents in EUCAST tables but not available Agents validated for MH-F Liofilchem Cefadroxil Cefalexin Roxithromycin Telithromycin Ticarcillin Amoxicillin Amoxicillin-clavulanic acid (fixed 2 mg/l clavulanic acid)* Ampicillin Ampicillin-sulbactam (fixed 4 mg/l sulbactam)* Azithromycin Benzylpenicillin Cefaclor Cefepime Cefixime Cefotaxime Cefpodoxime Ceftaroline Ceftriaxone Cefuroxime Cephalothin Chloramphenicol Ciprofloxacin Clarithromycin Clindamycin Doripenem Doxycycline Ertapenem Erythromycin Imipenem Levofloxacin Linezolid Meropenem Minocycline Moxifloxacin Ofloxacin Rifampicin Teicoplanin Tetracycline Trimethoprim-sulfamethoxazole Vancomycin *Gradient tests with the agent:inhibitor in a 2:1 ratio are not acceptable using EUCAST methods and breakpoints

Gradient tests: M.I.C.Evaluator (Thermo Fisher Scientific) Manufacturer Agents in EUCAST tables but not available Agents validated for MH-F Thermo Fisher Scientific (Oxoid) Amoxicillin-clavulanic acid (fixed 2 mg/l clavulanic acid)* Ampicillin-sulbactam (fixed 4 mg/l sulbactam)* Azithromycin Aztreonam Cefaclor Cefadroxil Cefalexin Cefazolin Cefepime Cefixime Cefoxitin Cefpodoxime Ceftibuten Ceftobiprole Ceftolozane-tazobactam Cefuroxime Chloramphenicol Clarithromycin Colistin Dalbavancin Doripenem Doxycycline Ertapenem Fosfomycin Fusidic acid Mecillinam Minocycline Moxifloxacin Mupirocin Nalidixic acid Netilmicin Nitrofurantoin Norfloxacin Ofloxacin Oitavancin Piperacillin Piperacillin-tazobactam Quinupristin-dalfopristin Rifampicin Roxithromycin Spectinomycin Streptomycin Tedizolid Telavancin Telithromycin Ticarcillin Ticarcillin-clavulanate Tobramycin Trimethoprim Trimethoprim-sulfamethoxazole Amoxicillin Ampicillin Benzylpenicillin Oxacillin Cefotaxime Ceftazidime Ceftaroline Levofloxacin Amikacin Teicoplanin Vancomycin Erythromycin Tetracycline Tigecycline Linezolid *Gradient tests with the agent:inhibitor in a 2:1 ratio are not acceptable using EUCAST methods and breakpoints

Phoenix/EpiCenter automated system (BD) EUCAST terminology In computer database S No (R ) - S EUCAST Expert Rules EUCAST organism groups with no test in the system Agents in EUCAST tables but not available in the system Agents available but EUCAST breakpoints not in the system In reports ( converted to ) - (MICs reported for agents with no EUCAST breakpoints) (MICs reported for agents with no EUCAST breakpoints) All rules incorporated. There are additional rules but EUCAST rules have priority. H. influenzae M. catarrhalis N. meningitidis N. gonorrhoeae Ampicillin-sulbactam (fixed 4 mg/l sulbactam)* Ceftobiprole Ceftolozane-tazobactam Gram-negative anaerobes Gram-positive anaerobes Rifampicin (Staphylococcus spp. cannot be reported susceptible) Trimethoprim (Enterococcus spp. cannot be reported susceptible) Trimethoprim-sulfamethoxazole (Enterococcus spp. cannot be reported susceptible) *Tests with the agent:inhibitor in a 2:1 ratio are not acceptable using EUCAST methods and breakpoints

MicroScan automated system (Beckman Coultier Diagnostics) S In computer database - No EUCAST terminology S No In reports - Most - do not have interpretations reported No EUCAST Expert Rules. There are other rules in the system but EUCAST rules take precedence for EUCAST panels. All rules can be customized by user. EUCAST organism groups with no test in the system M. catarrhalis Pasteurella N. meningitidis N. gonorrhoeae Gram-negative anaerobes Gram-positive anaerobes Agents in EUCAST tables but not available in the system Agents available but EUCAST breakpoints not in the system Doxycycline Roxithromycin Telithromycin Dalbavancin Oritavancin Tedizolid Chloramphenicol Fusidic acid Cefuroxime Ampicillin-sulbactam (fixed 4 mg/l sulbactam)* Amoxicillin-clavulanic acid (fixed 2 mg/l clavulanic acid)* Ceftobiprole Ceftolozane-tazobactam All agents for anaerobes Tigecycline (Gram-positive organisms) Rifampicin Trimethoprim *Tests with the agent:inhibitor in a 2:1 ratio are not acceptable using EUCAST methods and breakpoints

EUCAST terminology EUCAST Expert Rules EUCAST organism groups with no test in the system Agents in EUCAST tables but not available in the system Agents available but EUCAST breakpoints not in the system Compliance of manufacturers with EUCAST guidelines, 10 March 2016 VITEK 2 automated system (biomérieux) In computer database In reports S - S - H. influenzae Gram-negative anaerobes C. jejuni and coli M. catarrhalis Gram-positive anaerobes Corynebacterium spp. N. meningitidis H. pylori M. tuberculosis N. gonorrhoeae L. monocytogenes Azithromycin Roxithromycin Cefuroxime (S. pneumoniae ) Dalbavancin Ampicillin-sulbactam (fixed 4 mg/l sulbactam) * (Staphylococcus spp. and Enterococcus spp.) Phenoxymethylpenicillin Cefadroxil Ceftobiprole Ceftibuten Ceftolozane-tazobactam (expected during 2016) Daptomycin Doxycycline (S. pneumoniae ) ICR (S. pneumoniae, Viridans group, Strep. Gr. C & G) Minocycline (S. pneumoniae ) Oritavancin Tedizolid Telavancin Cefepime (S. pneumoniae) Cefpodoxime (S. pneumoniae) Netilmicin (Staphylococcus spp.) Trimethoprim (Enterococcus spp. and group B streptococci) Amoxicillin-clavulanic acid (fixed 2 mg/l clavulanic acid)* uncomplicated UTI breakpoints (Enterobacteriaceae) Doripenem (Enterobacteriaceae, Pseudomonas spp., Acinetobacter spp.) Ciprofloxacin (Salmonella spp. and Enterococcus spp.) Levofloxacin (Enterococcus spp.) Trim-sulfa (Enterococcus spp.) Ofloxacin (S. pneumoniae ) Streptomycin (Enterococcus spp.) Antifungals All agents with P. multocida Benzylpenicillin (CoNS) Cefoxitin screen (S. saprophyticus and S. pseudintermedius) Norfloxacin (Enterococcus spp.) *Tests with the agent:inhibitor in a 2:1 ratio are not acceptable using EUCAST methods and breakpoints All applicable rules dealing with intrinsic resistance, therapeutic interpretation and deduction are beginning with software version V2S 5.03 (2011). There are additional rules but none should be contrary to EUCAST rules in this software version.

Sensititre (Thermo Fisher Scientific) EUCAST terminology In computer database S - S EUCAST Expert Rules EUCAST organism groups with no test in the system Agents in EUCAST tables but not available in the system Agents available but EUCAST breakpoints not in the system In reports - All EUCAST rules are in software version 3.3 (2014). There are additional rules, but these rules are inactivated in the EUCAST setting. N. gonorrhoeae All agents available All agents for yeasts and molds

MICRONAUT (MERLIN Diagnostika GmbH) EUCAST terminology In computer database S - No S EUCAST Expert Rules EUCAST organism groups with no test in the system Agents in EUCAST tables but not available in the system Agents available but EUCAST breakpoints not in the system In reports - (MICs reported for agents with no EUCAST breakpoints) No (MICs reported for agents with no EUCAST breakpoints) All EUCAST rules are. There are additional rules in the software. Our rules can be customized by the user. N. gonorrhoeae Ceftolozane-tazobactam (expected during 2016) All agents for molds.

MIKROLATEST (Erba Mannheim) EUCAST terminology In computer database S - (I) S EUCAST Expert Rules EUCAST organism groups with no test in the system Agents in EUCAST tables but not available in the system Agents available but EUCAST breakpoints not in the system In reports - (I) EUCAST rules are in software version 20151105 (2015). There are additional rules in the software. The rules can be customized by the user. Gram-positive anaerobes N. gonorrhoeae Gram-negative anaerobes H. influenzae All agents for anaerobes, Corynebacterium spp., N. gonorrhoeae, H. influenzae None Corynebacterium spp.